Gut bacteria diversity, digestive health, probiotics, prebiotics, and the gut-brain axis
361 articoli
New research shows how a specific gut bacteria enhances anti-PD-1 therapy effectiveness in hard-to-treat colorectal cancers.
Engineered cerium-peptide microspheres show 76% reduction in IBD symptoms and 66% decrease in fibrosis markers in mouse studies.
Study reveals how plastic pollution in greenhouse farming increases over time and alters soil microbiomes critical for plant health.
Researchers develop 22-color flow cytometry to profile unconventional T cells that protect gut health and maintain immune balance.
First study to quantify food additives in Crohn's patients reveals higher sweetener levels and altered emulsifier metabolism tied to disease severity.
New research identifies bacterial genetic variations in children's gut microbiomes that may serve as diagnostic biomarkers for autism.
GOULASH trial compares feeding strategies for pancreatitis patients to optimize recovery outcomes.
Advanced sequencing shows antibiotics affect gut microbiome resistance differently, with amoxicillin causing most gene expression changes.
Dr. Tim Spector shares breakthrough findings from the largest microbiome study and why most probiotics are scientifically obsolete.
Multi-omics study reveals how specific gut microbes produce acetate to protect liver function and prevent metabolic disorders in dairy cows.
Bacterial metabolite from flavonoids protects against graft-versus-host disease while preserving anti-cancer effects in stem cell transplants.
New review reveals how gut microbiota interacts with radiation therapy, offering potential strategies to prevent treatment complications.
